Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-09

Clinical Trial Update: Low Dose Aspirin for Preventing Intrauterine Growth Restriction and Preeclampsia in Sickle Cell Pregnancy (PIPSICKLE) [Phase 3]

View source ↗

Summary

Phase 3 trial update (PIPSICKLE) evaluating low-dose aspirin to prevent intrauterine growth restriction and preeclampsia in pregnancies affected by sickle cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (low-dose) (acetylsalicylic acid)

Snippet

Sponsor: University of Lagos, Nigeria | Conditions: Intrauterine Growth Restriction, Preeclampsia | Phase 3 | Status: COMPLETED